Real Life Data and Outcome of FOLFIRINOX Use in Metastatic Pancreatic Cancer Patients in General Hospitals in the Netherlands

ConclusionSurvival rates for patient with metastatic pancreatic cancer treated with FOLFIRINOX were worse in our study population than in comparative studies.
Source: Journal of Gastrointestinal Cancer - Category: Cancer & Oncology Source Type: research